Professor Charles Swanton - Cancer evolution, immune evasion and metastatic progression - insights from TRACERx

Professor Charles Swanton - Cancer evolution, immune evasion and metastatic progression - insights from TRACERx
Prof Charles Swanton
UCL Cancer Institute & The Francis Crick Institute
Director, CRUK UCL Lung Cancer Centre

Rethinking Cancer | UCL Cancer Domain Symposium
Monday 13 May 2019
Cancer evolution: can we beat Nature?
Cancer remains one of the major causes of morbidity and premature death worldwide; one in two people in the UK born after 1960 will be diagnosed with some form of cancer during their lifetime. UCL has a proud track record in addressing the societal, technical, and health challenges of cancer and in exploring its underling biology.

This symposium, invited our broad community to assemble for the first time at scale to consider challenges and opportunities in cancer research, prevention and treatment, from biological, clinical, technical, economic and societal perspectives.
Teresa Baker
682
6/3/2019
00:32:34
UCL Cancer Domain, evolution, UCL Cancer Institute, The Francis Crick Institute, UCL Lung Cancer Centre, Charles Swanton, cancer, tumour evoloution, cancer mutation, Alison lloyd, Daniel Hochhauser, MRC Lab for Molecular Cell Biology, cruk, UCLH
Download